Concepedia

Author

Edward A. Sausville

National Cancer Institute

Also Known As

E A Sausville, E Sausville, E. A. SAUSVILLE, E. A. Sausville, E. Sausville, E.A. SAUSVILLE, E.A. Sausville, EDWARD A. SAUSVILLE, Edward A Sausville, Edward A. Sausville

484

Publications

39.6K

Citations

101

H-Index

205

Concepts

All Affiliations

National Cancer InstituteUniversity of Maryland, BaltimoreNational Institutes of HealthScience Applications International Corporation (United States)University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
EA

About

Edward A. Sausville is an author at National Cancer Institute specializing in medicine, pharmacology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

70

152

21.3K

2

Natural Sciences

28

35

4.2K

3

Health Sciences

9

9

2.3K

4

Engineering

3

3

110

5

Public Health

1

1

18

Edward A. Sausville

×

250

Publications

36.2K

Citations

94

H-Index

YearCitations

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

Julian Adams, Vito J. Palombella, Edward A. Sausville,

PubMed

1999

1.5K

A gene expression database for the molecular pharmacology of cancer

Uwe Scherf, Douglas T. Ross, Mark Waltham,

Nature Genetics

2000

1.4K

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Ingo Tamm, Yi Wang, Edward A. Sausville,

PubMed

1998

1.3K

An Information-Intensive Approach to the Molecular Pharmacology of Cancer

John N. Weinstein, Timothy G. Myers, P M O'Connor,

Science

1997

1.2K

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

P M O'Connor, Joany Jackman, I Bae,

PubMed

1997

881

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

J I Johnson, Shannon Decker, Daniel Zaharevitz,

British Journal of Cancer

2001

850

Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin.

M Bubb, Adrian M. Senderowicz, Edward A. Sausville,

Journal of Biological Chemistry

1994

815

L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer

Marion M. Nau, Burke J. Brooks, James F. Battey,

Nature

1985

663

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk Factors

Ashraf Badros, Dianna Weikel, Andrew Salama,

Journal of Clinical Oncology

2006

595

The Amino-terminal Domain of Heat Shock Protein 90 (hsp90) That Binds Geldanamycin Is an ATP/ADP Switch Domain That Regulates hsp90 Conformation

James P. Grenert, W. Patrick Sullivan, Patrick Fadden,

Journal of Biological Chemistry

1997

568

Page 1